Data from EMC - Curated by EPG Health - Last updated 04 August 2016


Pentostam should be used in accordance with international and local treatment guidelines. Consideration should be given to visceral leishmaniasis resistance patterns prior to administration.

Pentostam is indicated for the following diseases:

Visceral leishmaniasis (kala azar).

Cutaneous leishmaniasis.

South American mucocutaneous leishmaniasis.

Pentostam may also be of value in the treatment of leishmaniasis recidivans and diffuse cutaneous leishmaniasis in the New World.


- There is limited data available on the effectiveness of sodium stibogluconate to treat cutaneous and diffuse cutaneous leishmaniasis caused by Leishmania infantum and Leishmania aethiopica.


Full Prescribing information

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Inflammatory bowel disease assessment tools

Inflammatory bowel disease assessment tools

'New IBD assessment tools at a glance' - an educational symposium sponsored by Sandoz.

Atopic Dermatitis

Atopic Dermatitis

The Atopic Dermatitis Knowledge Centre is an educational resource, intended for healthcare professionals, that provides credible medical information on the epidemiology, pathophysiology and burden of atopic dermatitis, as well as diagnostic techniques, treatment regimens and guideline recommendations.

Inflammatory Bowel Disease Knowledge Centre

Inflammatory Bowel Disease Knowledge Centre

The Inflammatory Bowel Disease (IBD) Knowledge Centre contains key information relating to the epidemiology and pathophysiology of Crohn’s disease and ulcerative colitis, highlighting prevalence, impact and unmet needs and the underlying inflammatory processes that drive IBD, considering some of the key inflammatory pathways.

Load more

Related Content

More information

Category Value
Orphan designation No
Type POM
Marketing authorisation holder GlaxoSmithKline UK